News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Day In Review: Immunicon Corporation (IMMC) Rises On AstraZeneca PLC (AZN) Deal



8/7/2006 5:02:04 PM

August 7, 2006 -- Immunicon signed two agreements with AstraZeneca, one for biomarkers and the other for laboratory services; BioCryst has a Special Protocol Assessment for its cancer drug Fodosine; Corcept published positive results from a Phase II trial of Corlux, a drug for psychotic major depression;Taisho Pharma ended its partnership with Lilly on a drug for diabetes; Advanced Medical Optics sold 6 OTC eye-care products to Inyx; and Novelos Therapeutics received Fast Track designation for a lung cancer compound. The Centient Biotech 200™ fell 38 points to 3629.37, a loss of 1.03%. More details...

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES